What's monoclonal antibody (mAB)?
monoclonal antibody (mAB) ?A single type of antibody that is directed against a specific epitope (antigen, antigenic determinant) and is produced by a single clone of B cells or a single hybridoma cell line, which is formed by the fusion of a lymphocyte cell with a myeloma cell. Some myeloma cells synthesize single antibodies naturally. |
 |
|
|
|
|
 |
 |
|
|
2006-2-23
|
Shanghai Consultative Conference Chairman Jiang Yiren, Shanghai Consultative Conference Deputy Chairman Song Yiqiao, Shen Hongguang, Xie, Lijuan, Zuo, Huanchen, Wang, Ronghua accompanied by leaders from the promotion office of "City reviving through science and education advancement project" , the coordinating office of "City reviving through science and education advancement project" , Shanghai Development and Reform Commission, Shanghai Economic Committee and Pudong New Area Government conducted a survey on our progress of the "City reviving through science and education advancement project". |
|
|
2006-2-21
|
Seminar of Shanghai antibody medicine industrialization achievement was successfully convened. The seminar was joint-conducted by modern biology and medicine industrialization office of STCSM and CP Guojian. |
|
|
2006-1-25
|
Patent application number 02111092.1 attained invention patent certification issued by State Intellectual Property Office of P.R.C. |
|
|
2006-1-4
|
Patent application number 01132280.2 attained invention patent certification issued by State Intellectual Property Office of P.R.C |
|
|
2005-12-29
|
Our company signed special support agreement of “Wisdom Eyes Project” with Shanghai Pudong New Area Science and Technology Bureau. The company attained a 3-year loan of 4,500,000 Yuan to pay interest.
A few days ago, our company officially set up a toll-free national customer service number: 8008208170 to provide customers national-wide product introduction and consultation services. |
|
|
2005-11-21
|
Product “Recombinant Human Necrosis Factor-αReceptorⅡ:IgG Fc (rhTNFR:Fc) Fusion Protein for Injection” attained GMP certificate issued by State Food and drug Administration.
|
|
|
2005-11-1
|
Project “Research and development of new anti-rheumatic arthritis medicine” passed National Technical Department’s acceptance test. The project is national high-tech research development project (863 plans) undertaken by our company. |
|
|
2005-10-30
|
Clinical research phase 4 of “Recombinant Human Necrosis Factor-αReceptorⅡ:IgG Fc (rhTNFR:Fc) Fusion Protein for Injection” project officially started. |
|
|
2005-10-28
|
After rounds of experts’ argumentation, STCSM established Shanghai Antibody Technology and Science researching center” based upon our company. |
|
|
2005-10-19
|
'Recombinant human interleukin–11 for injection' attained GMP certificate issued by State Food and drug Administration.
|
|
| |
Copyright 2002-2006 Shanghai CP Guojian Pharmaceutical Co.,Ltd. |
|
